Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination.
Alexander J NajibiRyan S LaneMiguel C SobralGiovanni BovoneShawn KangBenjamin R FreedmanJoel Gutierrez EstupinanAlberto Elosegui-ArtolaChristina M TringidesMaxence O DellacherieKatherine WilliamsHamza IjazSören MüllerShannon J TurleyDavid J MooneyPublished in: Nature biomedical engineering (2024)
Following immunization, lymph nodes dynamically expand and contract. The mechanical and cellular changes enabling the early-stage expansion of lymph nodes have been characterized, yet the durability of such responses and their implications for adaptive immunity and vaccine efficacy are unknown. Here, by leveraging high-frequency ultrasound imaging of the lymph nodes of mice, we report more potent and persistent lymph-node expansion for animals immunized with a mesoporous silica vaccine incorporating a model antigen than for animals given bolus immunization or standard vaccine formulations such as alum, and that durable and robust lymph-node expansion was associated with vaccine efficacy and adaptive immunity for 100 days post-vaccination in a mouse model of melanoma. Immunization altered the mechanical and extracellular-matrix properties of the lymph nodes, drove antigen-dependent proliferation of immune and stromal cells, and altered the transcriptional features of dendritic cells and inflammatory monocytes. Strategies that robustly maintain lymph-node expansion may result in enhanced vaccination outcomes.
Keyphrases
- lymph node
- high frequency
- dendritic cells
- sentinel lymph node
- extracellular matrix
- neoadjuvant chemotherapy
- early stage
- mouse model
- transcranial magnetic stimulation
- immune response
- signaling pathway
- gene expression
- type diabetes
- oxidative stress
- adipose tissue
- radiation therapy
- peripheral blood
- metabolic syndrome
- skin cancer
- wild type
- basal cell carcinoma